Navigation Links
Eye Disease Rates High Among Latino Americans

As the population ages, more programs needed to address vision loss, experts say

SATURDAY, May 1 (HealthDay News) -- Latino Americans have higher rates of visual impairment, blindness, diabetic eye disease and cataracts than whites in the United States, researchers have found.

The analysis included data from more than 4,600 participants in the Los Angeles Latino Eye Study (LALES). Most of the study participants were of Mexican descent and aged 40 and older. In the four years after the participants enrolled in the study, the Latinos' rates of visual impairment and blindness were the highest of any ethnic group in the country, compared to other U.S. studies of different populations.

Nearly 3 percent of the study participants developed visual impairment and 0.3 percent developed blindness in both eyes. Among those aged 80 and older, 19.4 percent became visually impaired and 3.8 percent became blind in both eyes.

The study also found that 34 percent of participants with diabetes developed diabetic retinopathy (damage to the eye's retina), with the highest rate among those aged 40 to 59. The longer someone had diabetes, the more likely they were to develop diabetic retinopathy -- 42 percent of those with diabetes for more than 15 years developed the eye disease.

Participants who had visual impairment, blindness or diabetic retinopathy in one eye at the start of the study had high rates of developing the condition in the other eye, the study authors noted.

The researchers also found that Latinos were more likely to develop cataracts in the center of the eye lens than at the edge of the lens (10.2 percent versus 7.5 percent, respectively), with about half of those aged 70 and older developing cataracts in the center of the lens.

"This study showed that Latinos develop certain vision conditions at different rates than other ethnic groups. The burden of vision loss and eye disease on the Latino community is increasing as the population ages, and many eye diseases are becoming more common," Dr. Rohit Varma, principal investigator of LALES and director of the Ocular Epidemiology Center at the Doheny Eye Institute, University of Southern California, said in a news release from the U.S. National Eye Institute.

The findings are published in four reports in the May issue of the American Journal of Ophthalmology.

"These data have significant public health implications and present a challenge for eye care providers to develop programs to address the burden of eye disease in Latinos," Dr. Paul A. Sieving, director of the National Eye Institute, said in the news release.

The U.S. National Eye Institute provided funding for LALES.

More information

The U.S. Centers for Disease Control and Prevention has more about eye disorders.

-- Robert Preidt

SOURCE: U.S. National Eye Institute, news release, May 1, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Blood stem-cell transplant regimen reverses sickle cell disease in adults
2. New research identifies modifiable risk factors for heart disease
3. Distinct demographic profiles between Crohns disease and ulcerative colitis
4. Summit Medical Group hosts “Go Red Day” to Raise Awareness of Heart Disease and Stroke
5. Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs
6. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
7. Tests showing smokers their individual risk of future disease will help them quit, says paper
8. Researcher to track spread of disease, malware and power outages
9. Texas Health Dallas Launches Screening Program for Female Heart Disease
10. Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security
11. A better sign of blood vessel narrowing and early coronary artery disease
Post Your Comments:
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... Finnleo, ... through Christmas Eve on several models of traditional and far-infrared saunas. , ... Nordic Spruce is the most traditional Finnish sauna wood, and Finnleo uses only European ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at ... hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety ... fuller hair, without the need for surgery, prescription pills, or topical foams. , ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, ... Two Organizations, One Beat ” campaign. The partnership between the two groups began in ... in MAP International’s cause. , MAP International was founded in 1954 and is an ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... IL (PRWEB) , ... November 25, 2015 , ... The ... announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex ... Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... TEL AVIV, Israel , November 25, 2015 /PRNewswire/ ... firms (the "New Investors"), pursuant to which BioLight and ... in BioLight,s IOPtima Ltd. subsidiary ("IOPtima") via a private ... global commercialization of its innovative IOPtimate™ system used in ... a regulatory approval pathway process for the IOPtimate™ system ...
Breaking Medicine Technology: